According to a report from The National Center for Health Statistics, cirrhosis and chronic liver disease accounted for more than 25,000 deaths and 373,000 hospital discharges in the United States in 1998. Therefore, cirrhosis and chronic liver disease have a huge financial impact on the health care industry.
Cirrhosis cost-effectiveness of therapy
Hepatocellular carcinoma cost-effectiveness of therapy
Gallstone disease cost-effectiveness of therapy
Cholangitis cost-effectiveness of therapy
Cirrhosis tertiary prevention
Alcohol withdrawal cost-effectiveness of therapy
Ascending cholangitis cost-effectiveness of therapy
Cirrhosis future or investigational therapies